Cerebrotendinous Xanthomatosis
📧 Sign up to get email alerts when something new happens for Cerebrotendinous Xanthomatosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-11-18Clinical Trial Update: A Study of Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (CTX) [Phase 3]
A Phase 3 study evaluating chenodeoxycholic acid for cerebrotendinous xanthomatosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-10-14Clinical Trial Update: Cholestanol in Humans [NA]
A clinical trial evaluating cholestanol in humans for Cerebrotendinous Xanthomatosis has been withdrawn. The sponsor is listed as the US Dep…